FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine
Date: January 11, 2021
Issue #:
1615Summary:
The FDA has issued an Emergency Use Authorization
(EUA) for the Pfizer-BioNTech mRNA-based vaccine
for prevention of COVID-19 in persons≥16 years old.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: COVID-19 vaccines Source Type: research